CeQur is dedicated to helping people with diabetes manage their disease by developing and commercializing simple drug delivery devices that can be easily integrated into daily life. The company has a platform of simple, wearable, 3-day devices.
The PAQ line of products, are wearable insulin delivery devices used for 3 days at a time. Their simple, discreet design enables people to easily experience the benefits of intensive insulin therapy, while remaining free from the burdens of daily insulin injections. These devices allow a person to administer bolus doses of insulin with a simple click on the device. This can be done over clothing, so there is no reason to step away from friends to discreetly deliver a dose or to carry, handle and dispose of needles. CeQur has completed clinical studies evaluating PAQ devices among people with type 2 diabetes with positive improvements in A1C results.
CeQur is headquartered in Horw, Switzerland, with operations in Cardiff, United Kingdom and Marlborough, Massachusetts.
See CeQur related news here